NewsRx

Search our medical news database

Antares Pharma, Inc.

Stockholder of drug delivery devices company provides $4 million credit line

Published in Hospital and Nursing Home Week, November 17th, 2005

Antares Pharma, Inc. (AIS) announced that its largest stockholder, Jacques Gonella, has provided a line of credit of up to $4 million to help support ongoing activities as well as potential acquisitions.

Gonella is chairman of the board of directors of Antares Pharma and a major stockholder, owning in excess of 20% of Antares' outstanding shares. He is an active director of and investor in several privately held life science companies with a particular focus on drug delivery activities.

Previously, Gonella founded JAGO Pharma AG in 1983 and was its president and CEO until its acquisition in May 1996 by SkyePharma Plc, a London stock exchange company....

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook